Literature DB >> 11335777

The effect of plasma human immunodeficiency virus RNA and CD4(+) T lymphocytes on growth measurements of hemophilic boys and adolescents.

M W Hilgartner1, S M Donfield, H S Lynn, W K Hoots, E D Gomperts, E S Daar, D Chernoff, S K Pearson.   

Abstract

OBJECTIVE: The investigation examined the associations of plasma human immunodeficiency virus (HIV) RNA and CD4(+) T lymphocytes with height, weight, skeletal maturation, testosterone levels, and height velocity for hemophilic children and adolescents with HIV infection in the Hemophilia Growth and Development Study. STUDY
DESIGN: Two hundred seven participants were evaluated over 7 years.
RESULTS: A threefold increment in baseline plasma HIV RNA was associated with a 0.98-cm decrease in height and a 1.67-kg decrease in weight; 100-cells/microL decrements in baseline CD4(+) were associated with a 2.51-cm decrease in height and a 3.83-kg decrease in weight. Participants with high plasma HIV RNA (>3125 copies/mL) experienced significant delay in achieving maximum height velocity and lower maximum velocity compared with those with low viral load. The high CD4(+) (>243)/low plasma HIV RNA group had earlier age at maximum height velocity compared with the other 3 groups and higher maximum height velocity compared with the low CD4(+)/high plasma HIV RNA and low CD4(+)/low plasma HIV RNA groups. Decrements in CD4(+) were associated with decreases in bone age and testosterone level.
CONCLUSIONS: CD4(+) and HIV RNA were important in predicting growth outcomes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11335777     DOI: 10.1542/peds.107.4.e56

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  5 in total

1.  Predictors of growth and body composition in HIV-infected children beginning or changing antiretroviral therapy.

Authors:  C J Chantry; J S Cervia; M D Hughes; C Alvero; J Hodge; P Borum; J Moye
Journal:  HIV Med       Date:  2010-03-21       Impact factor: 3.180

2.  Delays in maturation among adolescents with hemophilia and a history of inhibitors.

Authors:  Sharyne M Donfield; Henry S Lynn; Alice E Lail; W Keith Hoots; Erik Berntorp; Edward D Gomperts
Journal:  Blood       Date:  2007-08-22       Impact factor: 22.113

3.  Impact of medications prescribed for treatment of attention-deficit hyperactivity disorder on physical growth in children and adolescents with HIV.

Authors:  Patricia A Sirois; Grace Montepiedra; Suad Kapetanovic; Paige L Williams; Deborah A Pearson; Kathleen Malee; Patricia A Garvie; Betsy L Kammerer; Sharon L Nichols; Molly L Nozyce; Mark Mintz; Wendy G Mitchell; James M Oleske
Journal:  J Dev Behav Pediatr       Date:  2009-10       Impact factor: 2.225

4.  Growth abnormalities in children with chronic hepatitis B or C.

Authors:  P Gerner; Andre Hörning; S Kathemann; K Willuweit; S Wirth
Journal:  Adv Virol       Date:  2012-03-04

5.  Assessment of Growth and Development in Children With Hepatitis B Positivity.

Authors:  Tugba Sari; Erdal Eren; Suda Tekin Koruk
Journal:  Gastroenterology Res       Date:  2014-12-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.